Cargando…

Quantitative Visualization of the Interaction between Complement Component C1 and Immunoglobulin G: The Effect of C(H)1 Domain Deletion

Immunoglobulin G (IgG) adopts a modular multidomain structure that mediates antigen recognition and effector functions, such as complement-dependent cytotoxicity. IgG molecules are self-assembled into a hexameric ring on antigen-containing membranes, recruiting the complement component C1q. In order...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanaka, Saeko, Nishiguchi, Shigetaka, Yogo, Rina, Watanabe, Hiroki, Shen, Jiana, Yagi, Hirokazu, Uchihashi, Takayuki, Kato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876274/
https://www.ncbi.nlm.nih.gov/pubmed/35216207
http://dx.doi.org/10.3390/ijms23042090
Descripción
Sumario:Immunoglobulin G (IgG) adopts a modular multidomain structure that mediates antigen recognition and effector functions, such as complement-dependent cytotoxicity. IgG molecules are self-assembled into a hexameric ring on antigen-containing membranes, recruiting the complement component C1q. In order to provide deeper insights into the initial step of the complement pathway, we report a high-speed atomic force microscopy study for the quantitative visualization of the interaction between mouse IgG and the C1 complex composed of C1q, C1r, and C1s. The results showed that the C1q in the C1 complex is restricted regarding internal motion, and that it has a stronger binding affinity for on-membrane IgG2b assemblages than C1q alone, presumably because of the lower conformational entropy loss upon binding. Furthermore, we visualized a 1:1 stoichiometric interaction between C1/C1q and an IgG2a variant that lacks the entire C(H)1 domain in the absence of an antigen. In addition to the canonical C1q-binding site on Fc, their interactions are mediated through a secondary site on the C(L) domain that is cryptic in the presence of the C(H)1 domain. Our findings offer clues for novel-modality therapeutic antibodies.